TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: ankle joint range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angular velocities in the sagittal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ground reaction force rate of loading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal Muscle Mass (SKMM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Throwing Velocity (TV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Situational awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient safety competency‐attitude
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: syncopal recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: syncope-free survival at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Bypassing rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Travel time to hospitals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Travel cost to hospitals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improved attitudes and knowledge of ECT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fast-food consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: macular thickness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resolution of macular edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude toward the legislation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decreasing anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increasing knowledge levels
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Metacognitions about Smartphone Use
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: dentin tag formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adipocyte volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased adipocyte glucose uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean OMAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of a non-drinking day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor uptake measured by SUVmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperglycaemia frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Postural control functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early tumor shrinkage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: rate of secondary metastatic resections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Subjective sleep satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Intraocular Pressure (IOP) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative probabilities of total success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall impact of cardiac rehabilitation program
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Annualized rate of severe asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Upregulation of platelet and lymphocyte markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: No adverse events or AR
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of hypercapnia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of respiratory adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in blood DHA (wt%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in blood ARA (wt%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint space reduction (JSD-MCPtotal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: DAS28 remission (DAS28 ≤ 2.6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major vascular, bleeding and ischemic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: functional balance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of social deficits
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improvement of autism severity
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improvement of empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perception of dyspnea
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LUTS/BPO improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood glucose levels before induction of anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum insulin levels before induction of anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalent obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cessation rates for harmful or hazardous drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hygienic prevention practices score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in proportion of risky drinking network members
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of days adherent
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total patient CQI scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Autonomic function in response to meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quicker onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of behavioral changes
Endpoint domain: Adverse events/effects
Primary endpoint: faster recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insomnia prevalence
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Development of CRS
Endpoint domain: Adverse events/effects
Primary endpoint: intraocular inflammation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cystoid macular edema (CME) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: increase in mean daily steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of participants showing an increase in mean daily steps of ≥1000
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported procedural pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-rated distress during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distress evaluated by proxy during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of seizures per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in knowledge and confidence about insulin pumps and CGM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Trunk impairment scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flare prediction AUROC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean subjective scores of SCORAD indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to correctly identify serving size
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Geometric Mean Fold Rise (GMFR) in antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acceptability of samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fear of childbirth score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum voluntary contractions for knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rectus femoris contraction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of asthma and treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence to manage symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Need for endoscopic transluminal necrosectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinicians' beliefs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Knowledge about low back pain care
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Care-seeking for noncommunicable diseases among adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score over 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall continence at 15 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFC at 15 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Instantaneous risk of HVCD-Any
Endpoint domain: Mortality/survival
Primary endpoint: MAXPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: aPWV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: peri- and postoperative morbidity and mortality
Endpoint domain: Adverse events/effects
Primary endpoint: Emotional support provided by PCP
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Support of clinical education by PCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of early postoperative periprosthetic fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Confidence regarding naloxone services implementation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intention regarding naloxone services implementation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of laboratory studies ordered after 7 AM
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of laboratory studies collected after 7 AM
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean number of yearly treatments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: onset times of labor analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of intrathecal injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: local anesthetic requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alzheimer's Disease (AD) risk
Endpoint domain: Mortality/survival
Primary endpoint: Bronchial cuff sealing volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased risk of infant mortality
Endpoint domain: Mortality/survival
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score subscale other symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stroke rate
Endpoint domain: Adverse events/effects
Primary endpoint: paravalvular leak (PVL) rate
Endpoint domain: Adverse events/effects
Primary endpoint: pregnancy rates after embryo transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of emicizumab
Endpoint domain: Adverse events/effects
Primary endpoint: Power output improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for propofol injection pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recalled pain in the PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grimace incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean XO activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in mRSS units
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migration of the implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Harris Hip Score (HHS) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip disability and osteoarthritis outcome score (HOOS) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanical ventilation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: annual slope of eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Psychological responses to physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physiological responses to physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sudden cardiac arrest (SCA)
Endpoint domain: Mortality/survival
Primary endpoint: incidence of pressure injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: skill performance of nursing assistants
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: wear rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drinks per day (DpDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualised moderate/severe exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in 1RM bench press
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gains in fat free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete or nearly complete IH resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: β-hydroxybutyrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain during rest intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFC activity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy in concurrent cognitive task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatiotemporal measures of turning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in color (luminosity, chroma, hue)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCeff
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intercanine width decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Little's Irregularity Index increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failures of retainers
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of NCPAP or mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Anxiety score ≥8
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depression score ≥8
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PCL-5 score ≥31
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in multiple-choice test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Relaxation face selection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective patient scoring of operating room experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall parkour time in seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall mistakes committed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adiponectin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Degree of hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Liver stiffness grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: History of cardiovascular disease (CVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy and safety of dapagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: examination scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge and confidence improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: satisfaction with e-module
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sleep quality (Leeds Sleep Evaluation Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Dialysis independence at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: quality-adjusted life-years (QALY) loss
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: maximal expiratory flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rPFS rate
Endpoint domain: Mortality/survival
Primary endpoint: Moderate and severe treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: LVEDV reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Discriminative ability of RID predictive model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deviation parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: processing speed and attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sequencing and mental flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle activation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting cortical activity in left superior frontal area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Freedom from AV access thrombosis or re-intervention
Endpoint domain: Mortality/survival
Primary endpoint: Nutritional quality of the shopping cart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Shopping times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measured clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of mechanical restraint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival probability at 180 days
Endpoint domain: Mortality/survival
Primary endpoint: percent achieving seroprotection (titers ≥0.1 IU/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: geometric mean antibody concentration ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma intact FGF23 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Urinary fractional phosphorus excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ASQoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quick Disabilities of the Arm, Shoulder and Hand score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total number of spermatozoa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Improvement in lifestyle habits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status